According to Redhill Biopharma's latest financial reports the company's current earnings (TTM) are HK$90.2 M. In 2022 the company made an earning of -HK$0.56 B an increase over its 2021 earnings that were of -HK$0.77 B.The earnings displayed on this page is the company's Pretax Income.